Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients

被引：0
|
作者：
Numan, L. [1 ]
Aarts, E. [2 ]
Ramjankhan, F. [3 ]
Van der Meer, M. G. [1 ]
Oerlemans, M. [4 ]
De Jonge, N. [1 ]
Oppelaar, A. [3 ]
Kemperman, H. [5 ]
Asselbergs, F. [4 ]
Van Laake, L. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[2] Univ Utrecht, Methodol Stat, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Cardiothorac Surg, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Cent Diagnost Lab, Utrecht, Netherlands
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2023年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
834
引用
收藏
页码：S364 / S365
页数：2
相关论文
共 50 条
  • [21] sST2 and mortality in acute heart failure
    Pauwels, Ruben
    Vandekerckhove, Hans
    De Puydt, Hendrik
    ACTA CARDIOLOGICA, 2019, 74 : 29 - 29
  • [22] Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension?
    Banaszkiewicz, M.
    Darocha, S.
    Pietrasik, A.
    Norwa, J.
    Dobosiewicz, A.
    Kepski, J.
    Florczyk, M.
    Manczak, R.
    Torbicki, A.
    Kurzyna, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1150 - 1150
  • [23] Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure A Meta-Analysis
    Aimo, Alberto
    Vergaro, Giuseppe
    Passino, Claudio
    Ripoli, Andrea
    Ky, Bonnie
    Miller, Wayne L.
    Bayes-Genis, Antoni
    Anand, Inder
    Januzzi, James L.
    Emdin, Michele
    JACC-HEART FAILURE, 2017, 5 (04) : 280 - 286
  • [24] Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
    Hildenbrand, Florian F.
    Illi, Barbara
    von Felten, Stefanie
    Bachofner, Jacqueline
    Gawinecka, Joanna
    von Eckardstein, Arnold
    Mullhaupt, Beat
    Mertens, Joachim C.
    Blumel, Sena
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [25] Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
    Florian F. Hildenbrand
    Barbara Illi
    Stefanie von Felten
    Jacqueline Bachofner
    Joanna Gawinecka
    Arnold von Eckardstein
    Beat Müllhaupt
    Joachim C. Mertens
    Sena Blümel
    BMC Gastroenterology, 24
  • [26] Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study*
    Ruiz-Castilla, Mireia
    Dos Santos, Bruce
    Vizcaino, Claudia
    Baena, Jacinto
    Guilabert, Patricia
    Marin-Corral, Judith
    Masclans, Joan R.
    Roca, Oriol
    Barret, Juan P.
    BURNS, 2021, 47 (04) : 906 - 913
  • [27] Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
    Sun, Yanxiang
    Feng, Li
    Hu, Bing
    Dong, Jianting
    Zhang, Liting
    Huang, Xuansheng
    Yuan, Yong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [28] A meta-analysis of soluble suppression of tumorigenicity 2(sST2) and clinical outcomes in pulmonary hypertension
    King Sum Luk
    Christina Ip
    MengQi GONG
    Sunny Hei WONG
    William KK Wu
    Mei DONG
    GuangPing LI
    Ka Pang Chan
    YiMei DU
    Tong LIU
    Martin CS Wong
    David Shu Cheong Hui
    Gary Tse
    Journal of Geriatric Cardiology, 2017, 14 (12) : 766 - 771
  • [29] A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension
    Luk, King Sum
    Ip, Christina
    Gong, Meng-Qi
    Wong, Sunny Hei
    Wu, William K. K.
    Dong, Mei
    Li, Guang-Ping
    Chan, Ka Pang
    Du, Yi-Mei
    Liu, Tong
    Wong, Martin C. S.
    Hui, David Shu Cheong
    Tse, Gary
    JOURNAL OF GERIATRIC CARDIOLOGY, 2017, 14 (12) : 766 - 771
  • [30] Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
    Nah, Eun-Hee
    Cho, Seon
    Kim, Suyoung
    Cho, Han-Ik
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (11)
12345